On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

Suven Pharmaceuticals Limited is a company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research and development, scale up and contract manufacturing of intermediates, active pharmaceutical ingredients (APIs) and formulations. Synopsis Pharma as a sector has been under pressure for a very long time. However, … Read more

MSMEs’ revenues to touch pre-COVID levels: Report

MSMEs’ revenues to touch pre-COVID levels: Report

Nearly all the MSMEs in the country this fiscal would be surpassing the revenues they achieved in the pre-covid level, but their operating profits may be well below the 2019 levels as they are not able to pass on the commodity price increases, said ratings firm Crisil. Almost all the MSMEs are expected to cross … Read more

MSMEs’ revenues to touch pre-COVID levels: Report

MSMEs’ revenues to touch pre-COVID levels: Report

Nearly all the MSMEs in the country this fiscal would be surpassing the revenues they achieved in the pre-covid level, but their operating profits may be well below the 2019 levels as they are not able to pass on the commodity price increases, said ratings firm Crisil. Almost all the MSMEs are expected to cross … Read more

Can Kansai Nerolac’s latest strategy help stock regain valuations of good old days?

Can Kansai Nerolac’s latest strategy help stock regain valuations of good old days?

The stock price of Kansai Nerolac was Rs 390.3 when the market closed on June 13, 2022. The stock had reached its all-time high of Rs 651.5 on January 18, 2021, and has declined by almost 40% from those levels. Synopsis Kansai Nerolac is a subsidiary of Kansai Paint Company of Japan, which has 74.99% … Read more